Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Matthew J, Everly"'
Autor:
Eric A. Engels, MD, Linda W. Jennings, PhD, Matthew J. Everly, PharmD, Ola Landgren, MD, PhD, Kazunori Murata, PhD, Elizabeth L. Yanik, PhD, Ruth M. Pfeiffer, PhD, Nicholas Onaca, MD, Goran B. Klintmalm, MD, PhD
Publikováno v:
Transplantation Direct, Vol 4, Iss 6, p e353 (2018)
Background. Posttransplant lymphoproliferative disorder (PTLD) is a neoplastic complication of transplantation, with early cases largely due to immunosuppression and primary Epstein-Barr virus infection. Etiology may differ for later-onset cases, but
Externí odkaz:
https://doaj.org/article/e9a2e86ba19341ea8ea1db4e51c9dd4f
Autor:
Elektra J. Papadopoulos, Stephen R. Karpen, Teun van Gelder, Nicole Spear, Ozlem Belen, C. Alex Page, Michelle Campbell, Amanda Klein, Inish O’Doherty, Renata Albrecht, Rita R. Alloway, Matthew J Everly, Paul G. Kluetz, Lori M. Minasian, Ergun Velidedeoglu, Sandra A. Mitchell, Ruth Sapir-Pichhadze
Publikováno v:
Transplantation, 105(5), 941-944. Lippincott Williams & Wilkins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cf69575d8888840c58d3e48922bbb8d
https://pure.eur.nl/en/publications/afe2be8c-a2ae-40c7-aee7-a49f67e7bd09
https://pure.eur.nl/en/publications/afe2be8c-a2ae-40c7-aee7-a49f67e7bd09
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific Reports
Scientific Reports
Machine learning (ML) has shown its potential to improve patient care over the last decade. In organ transplantation, delayed graft function (DGF) remains a major concern in deceased donor kidney transplantation (DDKT). To this end, we harnessed ML t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be4a331caf7d5a0c06d185944ef31b94
http://link.springer.com/article/10.1038/s41598-020-75473-z
http://link.springer.com/article/10.1038/s41598-020-75473-z
Publikováno v:
American Journal of Transplantation. 20:1650-1658
Understanding the correlation between transplant symptoms, health-related quality of life (HRQoL), and graft outcomes is needed to support patient-focused drug development and posttransplant management. A post-hoc analysis of patient-reported outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e21b0bb0373de0f77c733e3ac58abb05
https://doi.org/10.1111/ajt.15757
https://doi.org/10.1111/ajt.15757
Autor:
Mark D. Stegall, Carrie A. Schinstock, Andrew Bentall, Lynn D. Cornell, Matthew J Everly, Byron H. Smith, Manish J. Gandhi
Publikováno v:
American Journal of Transplantation. 19:1671-1683
We aimed to determine the long-term outcomes of eculizumab-treated, positive crossmatch (+XM) kidney transplant recipients compared with +XM and age-matched negative crossmatch (-XM) controls. We performed an observational retrospective study and exa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cfa6cc8251b32064cc2f07e0edc8f71
https://doi.org/10.1111/ajt.15175
https://doi.org/10.1111/ajt.15175
Autor:
Peter H. Sayre, Matthew J Everly, Josh Levitsky, Abraham Shaked, Michele DesMarais, Sandy Feng, Vadim Jucaud
Publikováno v:
Hepatology. 69:1273-1286
The development of human leukocyte antigen (HLA) donor-specific antibody/antibodies (DSA) is not well described in liver transplant (LT) patients undergoing immunosuppression (IS) withdrawal protocols despite the allograft risk associated with de nov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccd319417eeb65ff48c8931a3ad91863
https://doi.org/10.1002/hep.30281
https://doi.org/10.1002/hep.30281
Autor:
Carl E. Haisch, David B. Leeser, Heather Jones, Kristel Mclawhorn, Vadim Jucaud, Kimberly P. Briley, Matthew J Everly, Lorita M. Rebellato, Scott A. Kendrick
Publikováno v:
Transplantation. 104:S49-S50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8079af4faba9099ab788041777aec39b
https://doi.org/10.1097/01.tp.0000698508.30965.3e
https://doi.org/10.1097/01.tp.0000698508.30965.3e
Autor:
Stanley C. Jordan, Ashley Vo, Bong-Ha Shin, Edmund Huang, Matthew J Everly, Xiaohai Zhang, Mieko Toyoda, Jua Choi, Hao Zhang
Publikováno v:
Transplantation. 104(4)
Background Chronic antibody-mediated rejection (cAMR) results in the majority of renal allograft losses. Currently, there are no approved therapies. We recently reported on clinical use of tocilizumab (TCZ) for treatment of cAMR in HLA-sensitized kid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::689ced276ddf6f95df9fba792c26651c
https://pubmed.ncbi.nlm.nih.gov/32830994
https://pubmed.ncbi.nlm.nih.gov/32830994
Autor:
Kojiro Taura, Kojiro Nakamura, Ronald W. Busuttil, Jerzy W. Kupiec-Weglinski, Shinji Uemoto, Kentaro Kadono, Antony Aziz, Douglas G. Farmer, Matthew J Everly, Takahiro Ito, Kenneth J. Dery, Shoichi Kageyama, Fady M. Kaldas, Hirofumi Hirao
Publikováno v:
The Journal of clinical investigation, vol 129, iss 8
Sci Immunol
Sci Immunol
Although modifications of gut microbiota with antibiotics (Abx) influence mouse skin and cardiac allografts, its role in orthotopic liver transplantation (OLT) remains unknown. We aimed to determine whether and how recipient Abx pretreatment may affe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e3fc855d9ccaa336fb77ad31500903f
https://escholarship.org/uc/item/6s7969kd
https://escholarship.org/uc/item/6s7969kd
Autor:
Milagros Samaniego-Picota, Manish J. Gandhi, Vijay K. Sharma, Darshana Dadhania, Evan A. Farkash, Carrie A. Schinstock, Mark D. Stegall, Matthew J Everly, Byron H. Smith
Publikováno v:
Transplant International. 32
We aimed to evaluate patient factors including nonadherence and viral infection and de novo donor-specific antibody (dnDSA) characteristics [total immunoglobulin G (IgG), C1q, IgG3, and IgG4] as predictors of renal allograft failure in a multicenter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a1d9f25cca2bcff94d3c9799c2d6248